LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2627 | 4093 | 0.6420 | 0.4918 |
MCF7 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2825 | 4093 | 0.6902 | 0.5603 |
MCF7 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2171 | 4093 | 0.5306 | 0.3337 |
MCF7 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1105 | 4093 | 0.2701 | -0.0361 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2009 | 4093 | 0.4910 | 0.2775 |
MCF7 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1487 | 4093 | 0.3634 | 0.0963 |
MCF7 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2153 | 4093 | 0.5260 | 0.3272 |
MCF7 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2441 | 4093 | 0.5965 | 0.4272 |
MCF7 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 4055 | 4093 | 0.9908 | 0.9869 |
MCF7 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1504 | 4093 | 0.3675 | 0.1022 |
MCF7 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2084 | 4093 | 0.5093 | 0.3035 |
MCF7 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3726 | 4093 | 0.9105 | 0.8730 |
MCF7 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4049 | 4093 | 0.9893 | 0.9847 |
MCF7 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3857 | 4093 | 0.9425 | 0.9184 |
MCF7 | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2335 | 4093 | 0.5707 | 0.3905 |
MCF7 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1193 | 4093 | 0.2915 | -0.0057 |
MCF7 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1233 | 4093 | 0.3013 | 0.0081 |
MCF7 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2043 | 4093 | 0.4992 | 0.2892 |
MCF7 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 2753 | 4093 | 0.6726 | 0.5353 |
MCF7 | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 4013 | 4093 | 0.9806 | 0.9725 |
MCF7 | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 3494 | 4093 | 0.8538 | 0.7925 |
MCF7 | NU7441 | 0.37 | uM | LJP5 | 72 | hr | 1209 | 3777 | 4093 | 0.9230 | 0.8906 |
MCF7 | Dactolisib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 962 | 4093 | 0.2350 | -0.0859 |
MCF7 | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 964 | 4093 | 0.2357 | -0.0849 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2022 | 4093 | 0.4940 | 0.2818 |